{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:06Z","timestamp":1772136366628,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare and Ministry of science and ICT, Republic of Korea","award":["RS-2022-KH127756"],"award-info":[{"award-number":["RS-2022-KH127756"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare and Ministry of science and ICT, Republic of Korea","award":["RS-2022-KH127756"],"award-info":[{"award-number":["RS-2022-KH127756"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare and Ministry of science and ICT, Republic of Korea","award":["RS-2022-KH127756"],"award-info":[{"award-number":["RS-2022-KH127756"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare and Ministry of science and ICT, Republic of Korea","award":["RS-2022-KH127756"],"award-info":[{"award-number":["RS-2022-KH127756"]}]},{"name":"the \u201cKorea National Institute of Health\u201d research project","award":["2024-ER1003-00"],"award-info":[{"award-number":["2024-ER1003-00"]}]},{"name":"the \u201cKorea National Institute of Health\u201d research project","award":["2024-ER1003-00"],"award-info":[{"award-number":["2024-ER1003-00"]}]},{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["NRF-2019R1A5A2027340"],"award-info":[{"award-number":["NRF-2019R1A5A2027340"]}]},{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["NRF-2019R1A5A2027340"],"award-info":[{"award-number":["NRF-2019R1A5A2027340"]}]},{"name":"Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government","award":["No.RS-2021-II212068"],"award-info":[{"award-number":["No.RS-2021-II212068"]}]},{"name":"Artificial Intelligence Innovation Hub); Future Medicine 20*30 Project of the Samsung Medical Center","award":["#SMX1240561"],"award-info":[{"award-number":["#SMX1240561"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90642-8","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:53:07Z","timestamp":1740729187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of accumulation rates of beta-amyloid tracers and their relationship with cognitive changes"],"prefix":"10.1038","volume":"15","author":[{"given":"Soo Hyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heekyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongki","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohyun","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Chae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"90642_CR1","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau, M., Iaccarino, L., Soleimani-Meigooni, D. & Rabinovici, G. D. The role of amyloid PET in imaging neurodegenerative disorders: A review. J. Nucl. Med. 63, 13S-S19 (2022).","journal-title":"J. Nucl. Med."},{"key":"90642_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic, M. D. et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131, 1630\u20131645 (2008).","journal-title":"Brain"},{"key":"90642_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/mp.2014.9","volume":"19","author":"PM Doraiswamy","year":"2014","unstructured":"Doraiswamy, P. M. et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: A prospective multicenter study. Mol. Psychiatry 19, 1044\u20131051 (2014).","journal-title":"Mol. Psychiatry"},{"key":"90642_CR4","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne, V. L. et al. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J. Nucl. Med. 52, 1210\u20131217 (2011).","journal-title":"J. Nucl. Med."},{"key":"90642_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","volume":"50","author":"N Nelissen","year":"2009","unstructured":"Nelissen, N. et al. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J. Nucl. Med. 50, 1251\u20131259 (2009).","journal-title":"J. Nucl. Med."},{"key":"90642_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk, W. E. et al. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 11, 1\u201315 (2015).","journal-title":"Alzheimers Dement."},{"key":"90642_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13195-022-01099-0","volume":"14","author":"SJ Kim","year":"2022","unstructured":"Kim, S. J. et al. Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET. Alzheimers Res. Ther. 14, 157 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"90642_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"90642_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"90642_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3233\/JAD-200079","volume":"76","author":"SH Cho","year":"2020","unstructured":"Cho, S. H. et al. Head-to-head comparison of 18F-Florbetaben and 18F-Flutemetamol in the cortical and striatal regions. J. Alzheimers Dis. 76, 281\u2013290 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"90642_CR11","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00259-018-4081-5","volume":"45","author":"SH Cho","year":"2018","unstructured":"Cho, S. H. et al. Amyloid involvement in subcortical regions predicts cognitive decline. Eur. J. Nucl. Med. Mol. Imaging 45, 2368\u20132376 (2018).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"90642_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2020.03.011","volume":"93","author":"SJ Teipel","year":"2020","unstructured":"Teipel, S. J. et al. In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer\u2019s disease. Neurobiol. Aging 93, 98\u2013108 (2020).","journal-title":"Neurobiol. Aging"},{"key":"90642_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jalz.2018.04.011","volume":"14","author":"BJ Hanseeuw","year":"2018","unstructured":"Hanseeuw, B. J. et al. PET staging of amyloidosis using striatum. Alzheimers Dement. 14, 1281\u20131292 (2018).","journal-title":"Alzheimers Dement."},{"key":"90642_CR14","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00259-023-06209-0","volume":"50","author":"CD Chen","year":"2023","unstructured":"Chen, C. D. et al. Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a Phase 2\/3 clinical trial of anti-amyloid-beta monoclonal antibodies in dominantly inherited Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 50, 2669\u20132682 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"90642_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2019.02.020","volume":"79","author":"T Timmers","year":"2019","unstructured":"Timmers, T. et al. Amyloid PET and cognitive decline in cognitively normal individuals: The SCIENCe project. Neurobiol. Aging 79, 50\u201358 (2019).","journal-title":"Neurobiol. Aging"},{"key":"90642_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel, H. et al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: A multicentre phase 2 diagnostic study. Lancet Neurol. 10, 424\u2013435 (2011).","journal-title":"Lancet Neurol."},{"key":"90642_CR17","doi-asserted-by":"publisher","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust, W. J. & Landau, S. M. Temporal dynamics of \u03b2-amyloid accumulation in aging and Alzheimer disease. Neurology 96, e1347\u2013e1357 (2021).","journal-title":"Neurology"},{"key":"90642_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-150732","volume":"52","author":"TG Beach","year":"2016","unstructured":"Beach, T. G., Thal, D. R., Zanette, M., Smith, A. & Buckley, C. Detection of striatal amyloid plaques with [18F]flutemetamol: Validation with postmortem histopathology. J. Alzheimers Dis. 52, 863\u2013873 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"90642_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-018-0387-6","volume":"10","author":"MD Ikonomovic","year":"2018","unstructured":"Ikonomovic, M. D., Fantoni, E. R., Farrar, G. & Salloway, S. Infrequent false positive [(18)F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques. Alzheimers Res. Ther. 10, 60 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"90642_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","volume":"126","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr., Barrio, J. R. & Kepe, V. Cerebral amyloid PET imaging in Alzheimer\u2019s disease. Acta Neuropathol. 126, 643\u2013657 (2013).","journal-title":"Acta Neuropathol."},{"key":"90642_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran, E., Mercken, M. & Strooper, B. D. The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698\u2013712 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"90642_CR22","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","volume":"317","author":"MC Donohue","year":"2017","unstructured":"Donohue, M. C. et al. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA 317, 2305\u20132316 (2017).","journal-title":"JAMA"},{"key":"90642_CR23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A. et al. Donanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 384, 1691\u20131704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"90642_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn, H. J. et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci. 25, 1071\u20131076 (2010).","journal-title":"J. Korean Med. Sci."},{"key":"90642_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: Clinical characterization and outcome. Arch. Neurol. 56, 303\u2013308 (1999).","journal-title":"Arch. Neurol."},{"key":"90642_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"90642_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.0000000000000360","volume":"82","author":"GH Kim","year":"2014","unstructured":"Kim, G. H. et al. Seoul criteria for PiB(-) subcortical vascular dementia based on clinical and MRI variables. Neurology 82, 1529\u20131535 (2014).","journal-title":"Neurology"},{"key":"90642_CR28","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00259-019-04596-x","volume":"47","author":"SH Cho","year":"2020","unstructured":"Cho, S. H. et al. A new Centiloid method for (18)F-florbetaben and (18)F-flutemetamol PET without conversion to PiB. Eur. J. Nucl. Med. Mol. Imaging 47, 1938\u20131948 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90642-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90642-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90642-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:53:17Z","timestamp":1740729197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90642-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90642"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90642-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5209108\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7072"}}